Aging-Related Memory Disorders Alzheimer’s Disease From Mechanisms of Memory by J. David Sweatt, Ph.D.

Slides:



Advertisements
Similar presentations
Alzheimer’s Disease Savidra Lucatero, Vinita Mehrotra, Sabrina Rawlings, Jackie Wheeler, & Matt Zustiak.
Advertisements

Effect of Liraglutide Treatment on Inflammation and Oxidative Stress in Young and Old APP/PS1 and WT Mice Supervisors: Dr. Christian Holscher Dr. Kerry.
Disorders with Complex Genetics Alzheimer’s Disease.
Alzheimer’s Disease Edwin Onattu P. 3.
Etiopathogenesis of Alzheimer's disease
BME 482 Kevin Sylvestre.  35 million cases of Alzheimer’s disease (AD) in U.S. alone  Causes are widely studied  Leading theory- Amyloid Cascade Hypothesis.
This is only for personal educational purposes.
ALZHEIMER’S DISEASE Erin Dancey. Overview Alzheimer’s is the most common cause of dementia in adult life and is associated with the selective damage of.
Disorders with Complex Genetics DCGs. Signs & Symptoms: Memory loss for recent events Progresses into dementia  almost total memory loss Inability to.
ALZHEIMER'S DISEASE (AD)
MECHANISMS OF AGING TheoryPrinciples DNA & Genetic Theory Aging is predetermined by genetic programming. Neuroendocrine Theory Loss of hypothalamic regulation.

Amyloid beta protein may initiate a cascade leading to AD pathology.
Aging of the Nervous System: Functional Changes P.S. Timiras.
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
Comparison of Plaque Burden in Tg2576 Mice Using the Aperio and TurboScan Imaging Platforms A.J. Milici.
The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. Susan A. Farr, et al.
Nature may have the answers for Alzheimer’s disease Sungkwon Chung Dept. of Physiology Sungkyunkwan University School of Medicine.
Roderic G. Eckenhoff, MD Dept. Anesthesiology & Critical Care, University of Pennsylvania Hypothesis: Inhaled anesthetics.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Disorders with Complex Genetics. Signs & Symptoms: Memory loss for recent events Progresses into dementia  almost total memory loss Inability to converse,
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Molecular mechanism for Alzheimer’s disease : searching for the possible therapeutic targets Sungkwon Chung Dept. of Physiology Sungkyunkwan Univ. School.
Alzheimer’s Disease BRAIN, THE FINAL FRONTIER BRAIN, THE FINAL FRONTIER Kiminobu Sugaya, Ph.D.
Heterotrimeric G protein signalling in the plant kingdom by Daisuke Urano, Jin-Gui Chen, José Ramón Botella, and Alan M. Jones Open Biology Volume 3(3):
?v=pQO3Tq3KQL4 ohlTE.
Dr. Sigal fleisher-Berkovich Neuroinflammation is regulated by angiotensin related drugs: possible implications for neurodegenerative diseases.
CLINICAL AND RESEARCH MEMORY CENTER LARIBOISIERE HOSPITAL PARIS FRANCE UNIVERSITY OF PARIS DIDEROT INSERM UNIT 942 INVOLVEMENT OF PKR IN ALZHEIMER’S DISEASE.
Copper and Zinc Coordination mode in  -Amyloid Peptides A XAS and ab initio study ABR2008, Aprile 2008, Roma V. Minicozzi Phys. Dept.- University.
Cerebrovascular function with aging and in Alzheimer’s disease Alzheimer’s disease, Aβ and vascular hypotheses. Assessment of cerebral autoregulation and.
Cotinine: Potential Therapeutic agent in Alzheimer’s Disease Sharmila Thiagarajan C1 Bio-tech.
Alzheimer’s Disease Today and Tomorrow First case reported in 1906 Reported by Alois Alzheimer Patient Augusta D. first treated at 46 years old Paranoia,
Alzheimer’s Disease and the influence of Presenilin 1 By Tony Cortez.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part B – AD and brain systems NUCLEAR MEDICINE GRAND ROUNDS.
Pathogenesis of Alzheimer’s Disease-Approached by Multiphoton Microscopy 한림의대 병리학교실 최 경찬.
Measuring the Effect of Silencing the APP gene and Stimulating the CaMKII Pathway on Synaptic Plasticity in Alzheimer’s Disease Harshita Nangunuri.
Presenilin 1/2 and their mutation in Alzheimer Disease
Alzheimer’s Disease and the influence of Presenilin 1
Applications of Nanotechnology in Alzheimer’s Disease BioE 494 – Atomic and Molecular Nanotechnology Fall 2007 Deivya Bansal.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Absence of β-Amyloid Deposits After Immunization in.
Copper Complexes as Reactive Oxygen Species Donators Hannah Kiser and Tom E. Bitterwolf Department of Chemistry, University of Idaho, Moscow, ID Synthesis:
Measuring the Effect of Silencing the APP gene and Stimulating the CaMKII Pathway on Synaptic Plasticity in Alzheimer’s Disease Harshita Nangunuri.
21st Young Neuroscientist Meeting
Copyright © 2004 American Medical Association. All rights reserved.
Amyloid Angiopathy and Variability in Amyloid β Deposition Is Determined by Mutation Position in Presenilin-1-Linked Alzheimer’s Disease  David M.A. Mann,
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Alzheimer’s Disease CNS Block.
Small section of the neocortex from a patient with Alzheimer disease showing two classical neuropathologic lesions of the disease. A. The modified silver.
Alzheimer’s Disease.
Volume 17, Issue 5, Pages (November 1996)
Alzheimer’s Disease 1 in 9 people in the US aged 65 and older
65 year-old female with Alzheimer’s disease
Alzheimer Disease Mayo Clinic Proceedings
Q: How can we prevent or treat Alzheimer’s Disease?
Disorders with Complex Genetics
Volume 19, Issue 4, Pages (October 1997)
Q: How can we prevent or treat Alzheimer’s Disease?
Scott A. Small, Karen Duff  Neuron 
Neuroplasticity Failure in Alzheimer's Disease
Volume 16, Issue 21, Pages R906-R910 (November 2006)
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Alzheimer’s Disease Neurobiology
[18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β.
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Ab-dependent synaptic loss and neuritic dystrophies in adult APP/PSEN1 and APP/PSEN1/APOEnull mice. Ab-dependent synaptic loss and neuritic dystrophies.
Mouse and Drosophila models of AD
Genetic inhibition of PKA in the adult impairs memory for contextual fear conditioning. Genetic inhibition of PKA in the adult impairs memory for contextual.
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Abnormal morphologies are prevented by overexpression of CaN inhibitory peptide AKAP79 in APP/PS1 mouse brain. Abnormal morphologies are prevented by overexpression.
Presentation transcript:

Aging-Related Memory Disorders Alzheimer’s Disease From Mechanisms of Memory by J. David Sweatt, Ph.D.

Amyloid Plaques and Neurofibrillary Tangles Image by Poul Jorgensen, Claus Bus, Niels Pallisgaard, Marianne Bryder, and Arne Lund Jorgensen

A B C Terminus N Terminus Crystal Structure of Amyloid Beta Peptide Watson et al (1998) Biochemistry 37:

 Amyloid Precursor Protein (APP) Price, Sisodia and Borchelt (1998) Science 282:

Tg 2576 Tg PS1 A246E PS1 A246E FAD Mutant Transgene Accelerates Amyloid Plaque Pathology in Tg2576 Transgenic Mice Dineley et al (2002) J. Biol Chem. 277:

Fear Conditioning percent freezing Cued percent freezing Context 2 Pairings percent freezing Training APP K670N, M671L n=9 Double n=9 Wild Type n=9 PS-1 M146L n= Dineley et al (2002) J. Biol Chem. 277:

Diagnosing AD a: Neuritic Plaques b: Diffuse Plaques c: Neurofibrillary Tangles d. Amyloid in blood vessel walls Khachaturian and Radebaugh (1996). Boca Raton: CRC Press.

A B From Wang et al. (2000) The Journal of Biological Chemistry 275: The Cholinergic Hypothesis of AD